Loading clinical trials...
Loading clinical trials...
Real World Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention (MONITOR Study)
Conditions
Interventions
Tappt
Locations
6
United States
Tulane University
New Orleans, Louisiana, United States
Capital Digestive Care
Chevy Chase, Maryland, United States
New York University
New York, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
University of Cincinnati
Cincinnati, Ohio, United States
Vanderbilt University
Nashville, Tennessee, United States
Start Date
May 5, 2025
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
May 8, 2025
NCT06372613
NCT07550673
NCT07374471
NCT06071312
NCT05739864
NCT04338204
Lead Sponsor
Mercy Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions